In Illinois, researchers discovered how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma, develops and found a compound that can flip the switch on cancer-promoting genes turning them off so the tumor shrinks. Researchers used biopsied tumor samples from patients to create the lab models and it took less than two years for them to make the discovery. Considering only 5 percent of children with this brain tumor survive, being able to shrink tumors and increase survival rates in animal models is giving major hope for children and their parents. Clinical trials will begin at the Ann & Robert H. Lurie Children’s Hospital of Chicago by the end of the year.
Latest article
Planet-friendly pyrotechnics: Fireworks industry adopts renewable materials
In the United Kingdom, Chorlton Fireworks is leading a fireworks industry charge to replace plastic components with biodegradable materials where possible. Chorlton is already...
Popular Nivea skin cream gets natural ingredient makeover
In Germany, Beiersdorf has launched a line extension for its best-selling Nivea Crème that is 99% natural-origin ingredients—a feat that took six years of...
Argentinian students win Industria Inspira contest with sodium alginate water capsules
In Argentina, four students have won the Industria Inspira national contest for creating edible and biodegradable capsules that holding drinking water.
Made of sodium...